Submitted:
01 April 2026
Posted:
01 April 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design and Study Population
2.2. Inclusion and Exclusion Criteria
2.3. Study Protocol
3. Results

4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| SVV | sound-based voided volume |
| TVV | true-voided volume |
| LUTS | lower urinary tract symptoms |
References
- Zhang, AY; Xu, X. Prevalence, Burden, and Treatment of Lower Urinary Tract Symptoms in Men Aged 50 and Older: A Systematic Review of the Literature. SAGE Open Nurs Published. 2018, 4, 2377960818811773. [Google Scholar] [CrossRef] [PubMed]
- Przydacz, M; Golabek, T; Dudek, P; Lipinski, M; Chlosta, P. Prevalence and bother of lower urinary tract symptoms and overactive bladder in Poland, an Eastern European Study. Sci Rep. Published. 2020, 10(1), 19819. [Google Scholar] [CrossRef] [PubMed]
- Irwin, DE; Milsom, I; Kopp, Z; Abrams, P; Artibani, W; Herschorn, S. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder. Eur Urol. 2009, 56(1), 14–20. [Google Scholar] [CrossRef] [PubMed]
- Irwin, DE; Milsom, I; Hunskaar, S; Reilly, K; Kopp, Z; Herschorn, S; Coyne, K; Kelleher, C; Hampel, C; Artibani, W; Abrams, P. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006, 50(6), 1306–1315. [Google Scholar] [CrossRef] [PubMed]
- Egan, KB. The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates. Urol Clin North Am. 2016, 43(3), 289–297. [Google Scholar] [CrossRef] [PubMed]
- Wennberg, AL; Molander, U; Fall, M; Edlund, C; Peeker, R; Milsom, I. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women. Eur Urol. 2009, 55(4), 783–791. [Google Scholar] [CrossRef] [PubMed]
- Welch, G; Weinger, K; Barry, MJ. Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study. Urology 2002, 59(2), 245–250. [Google Scholar] [CrossRef] [PubMed]
- Sinha, S. The Use of Uroflowmetry as a Diagnostic Test. Curr Urol Rep. 2024, 25(5), 99–107. [Google Scholar] [CrossRef] [PubMed]
- Rangganata, E; Rahardjo, HE; Rasyid, N; Widia, F; Murwantara, IM; Yugopuspito, P; Gemilang, B; Nasher, FZ; Syadza, YZ; Yonathan, K; Birowo, P. Comparative study of mobile acoustic uroflowmetry and conventional uroflowmetry: A systematic review and meta analysis. Neurourol Urodyn 2024, 43(3), 694–702. [Google Scholar] [CrossRef] [PubMed]
- Kim, H; Ye, C; Jung, G; Ryu, H; Lee, JW; Jeong, SJ; Lee, S. Validation of acoustic voided volume measure: a pilot prospective study. World J Urol 2023, 41(2), 509–514. [Google Scholar] [CrossRef] [PubMed]
- Jung, G; Ryu, H; Lee, JW; Jeong, SJ; Margolis, E; Grover, N; Lee, S. Validation of an algorithm for sound-based voided volume estimation. Sci Rep. 2024, 14(1), 138. [Google Scholar] [CrossRef] [PubMed]
- Kim, JK; Kim, H; Ho, JN; Jeong, SJ; Lee, S. A Novel Acoustic Uroflowmetry-Based Mobile App Voiding Diary: Comparison with Conventional Paper-Based Voiding Diary. Biomed Res Int. Published. 2022, 2022, 3390338. [Google Scholar] [CrossRef] [PubMed]


| Clinical Factor | Value |
|---|---|
| Participants (Total) Male Female |
11 |
| 7 | |
| 4 | |
| Age (Years) Male Female |
|
| 25.9 (median) | |
| 25.0 (median) |
| Measurements | Values |
|---|---|
| Number of total void measurements Male Female |
82 |
| 42 | |
| 40 | |
| Range of VV measured by mobile application (SVV) (mL) Male Female |
|
| 42-790 28-440 | |
| Range of VV measured by HB-150-high-resolution (TVV) (mL) Male Female |
|
| 61-880 | |
| 10-682 | |
| Mean difference between SVV and TVV measures (mL) Male Female |
39 (95% CI, 18-59) |
| 53 (95% CI, 22-84) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).